CymaBay Therapeutics (CBAY) Misses Q4 EPS by 4c

CymaBay Therapeutics (NASDAQ: CBAY) reported Q4 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on CymaBay Therapeutics (CBAY) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Burry doubles down on Nebius short after stock surges 34% on earnings